All Cases

Market Entry / Go-To-Market

Simulated pricing discount expectations and business impact of four successive label expansions of a blockbuster oncology franchise 

Analyzed a market entry strategy for a large, global pharmaceutical company to ensure it aligned with expected capacity and could be supported by its expected economic impact

Market and patient access scenario planning for a pipeline hemophilia asset

State Medicaid coverage assessment for a novel hemophilia drug

Evaluated and refined promotional materials with robust market research methodologies

Developed a targeting approach based on identification and definition of key HCP segments to inform a go-to-market strategy

Strategic positioning of a Parkinson’s Disease therapy being launched in US and EU

Commercial root cause analysis and revised, enhanced commercial strategy for a Parkinson’s Disease treatment

Characterized and segmented the treatment ecosystem for relapsing multiple sclerosis (MS) to inform patient- and ecosystem-support strategies and promote a robust launch for a small biotech